DT vs NTNX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Dynatrace exhibits a stable financial health profile with a Piotroski F-Score of 4/9 and a pristine balance sheet (Debt/Equity 0.03). However, there is a severe valuation disconnect, as the current price of $35.29 trades significantly above the Graham Number ($11.13) and Intrinsic Value ($4.20). While the company maintains elite gross margins (81.75%) and a consistent track record of earnings beats, the massive YoY earnings decline (-89.10%) and bearish technical trend (0/100) offset the bullish analyst consensus.
Nutanix demonstrates exceptional fundamental health with a Piotroski F-Score of 8/9, signaling strong operational efficiency and financial stability. While the stock is currently in a severe technical downtrend (0/100), the valuation is highly attractive on a growth-adjusted basis with a PEG ratio of 0.86 and a Forward P/E of 17.66. The company maintains elite gross margins of 87.13% and a remarkable track record of beating earnings estimates over 25 consecutive quarters. Despite trading above the growth-based intrinsic value of $28.32, the combination of earnings acceleration and analyst targets suggests a strong recovery potential.
Compare Another Pair
Related Comparisons
DT vs NTNX: Head-to-Head Comparison
This page compares Dynatrace, Inc. (DT) and Nutanix, Inc. (NTNX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.